Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $243.95 | Total: $1,219.75 |
| 1 | 10 | $206.64 | Total: $2,066.40 |
| 1 | 25 | $175.07 | Total: $4,376.75 |
| 1 | 50 | $149.24 | Total: $7,462.00 |
| 1 | 100 | $129.15 | Total: $12,915.01 |
Overview
STX-478 is an orally active and selective PI3K? inhibitor that penetrates the blood-brain barrier and has anticancer activity to inhibit tumor growth.STX-478 is indicated for the study of breast cancer and other cancers.
Chemical Properties
| Molecular Formula | C16H12F5N5O2 |
| Molecular Weight | 401.29 |
| CAS Numbers | 2883540-92-7 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | [C@H](NC(NC=1C=NC(N)=NC1)=O)(C(F)(F)F)C2=C(C)C=3C(O2)=C(F)C=C(F)C3 |
Storage and Handling
0C Short Term, -20C Long Term
References
JR David St Jean, et al. Urea derivatives which can be used to treat cancer. Patent WO2022265993A1.